270 related articles for article (PubMed ID: 32422339)
1. 2020 Recommendations from the French Society of Rheumatology for the management of gout: Management of acute flares.
Latourte A; Pascart T; Flipo RM; Chalès G; Coblentz-Baumann L; Cohen-Solal A; Ea HK; Grichy J; Letavernier E; Lioté F; Ottaviani S; Sigwalt P; Vandecandelaere G; Richette P; Bardin T
Joint Bone Spine; 2020 Oct; 87(5):387-393. PubMed ID: 32422339
[TBL] [Abstract][Full Text] [Related]
2. 2020 recommendations from the French Society of Rheumatology for the management of gout: Urate-lowering therapy.
Pascart T; Latourte A; Flipo RM; Chalès G; Coblentz-Baumann L; Cohen-Solal A; Ea HK; Grichy J; Letavernier E; Lioté F; Ottaviani S; Sigwalt P; Vandecandelaere G; Richette P; Bardin T
Joint Bone Spine; 2020 Oct; 87(5):395-404. PubMed ID: 32422338
[TBL] [Abstract][Full Text] [Related]
3. Difficult-to-treat gout flares: eligibility for interleukin-1 inhibition in private practice is uncommon according to current EMA approval.
Pascart T; Norberciak L; Ea HK; Graf S; Guggenbuhl P; Lioté F
Rheumatology (Oxford); 2019 Dec; 58(12):2181-2187. PubMed ID: 31177284
[TBL] [Abstract][Full Text] [Related]
4. 2016 updated EULAR evidence-based recommendations for the management of gout.
Richette P; Doherty M; Pascual E; Barskova V; Becce F; Castañeda-Sanabria J; Coyfish M; Guillo S; Jansen TL; Janssens H; Lioté F; Mallen C; Nuki G; Perez-Ruiz F; Pimentao J; Punzi L; Pywell T; So A; Tausche AK; Uhlig T; Zavada J; Zhang W; Tubach F; Bardin T
Ann Rheum Dis; 2017 Jan; 76(1):29-42. PubMed ID: 27457514
[TBL] [Abstract][Full Text] [Related]
5. Nonsteroidal anti-inflammatory drugs and colchicine to prevent gout flare during early urate-lowering therapy: perspectives on alternative therapies and costs.
Peterson DM
J Pain Palliat Care Pharmacother; 2010 Dec; 24(4):402-4. PubMed ID: 21133751
[TBL] [Abstract][Full Text] [Related]
6. Managing Gout Flares in the Elderly: Practical Considerations.
Abhishek A
Drugs Aging; 2017 Dec; 34(12):873-880. PubMed ID: 29214511
[TBL] [Abstract][Full Text] [Related]
7. Prophylaxis for acute gout flares after initiation of urate-lowering therapy.
Latourte A; Bardin T; Richette P
Rheumatology (Oxford); 2014 Nov; 53(11):1920-6. PubMed ID: 24758886
[TBL] [Abstract][Full Text] [Related]
8. Diagnosis and management of acute gout.
Conway N; Schwartz S
Med Health R I; 2009 Nov; 92(11):356-8. PubMed ID: 19999893
[TBL] [Abstract][Full Text] [Related]
9. Gout: nonsteroidal anti-inflammatory drugs and colchicine to prevent painful flares during early urate-lowering therapy.
Kuritzky L; Panchal R
J Pain Palliat Care Pharmacother; 2010 Dec; 24(4):397-401. PubMed ID: 21133750
[TBL] [Abstract][Full Text] [Related]
10. GOSPEL 3: Management of gout by primary-care physicians and office-based rheumatologists in France in the early 21st century - comparison with 2006 EULAR Recommendations.
Goossens J; Lancrenon S; Lanz S; Ea HK; Lambert C; Guggenbuhl P; Saraux A; Delva C; Sahbane S; Lioté F
Joint Bone Spine; 2017 Jul; 84(4):447-453. PubMed ID: 28411137
[TBL] [Abstract][Full Text] [Related]
11. Managing your patient with gout: a review of treatment options.
Doghramji PP
Postgrad Med; 2011 May; 123(3):56-71. PubMed ID: 21566416
[TBL] [Abstract][Full Text] [Related]
12. Management of acute and chronic gouty arthritis: present state-of-the-art.
Schlesinger N
Drugs; 2004; 64(21):2399-416. PubMed ID: 15481999
[TBL] [Abstract][Full Text] [Related]
13. Evolution of management of gout: a comparison of recent guidelines.
Khanna PP; FitzGerald J
Curr Opin Rheumatol; 2015 Mar; 27(2):139-46. PubMed ID: 25611299
[TBL] [Abstract][Full Text] [Related]
14. 2020 American College of Rheumatology Guideline for the Management of Gout.
FitzGerald JD; Dalbeth N; Mikuls T; Brignardello-Petersen R; Guyatt G; Abeles AM; Gelber AC; Harrold LR; Khanna D; King C; Levy G; Libbey C; Mount D; Pillinger MH; Rosenthal A; Singh JA; Sims JE; Smith BJ; Wenger NS; Bae SS; Danve A; Khanna PP; Kim SC; Lenert A; Poon S; Qasim A; Sehra ST; Sharma TSK; Toprover M; Turgunbaev M; Zeng L; Zhang MA; Turner AS; Neogi T
Arthritis Rheumatol; 2020 Jun; 72(6):879-895. PubMed ID: 32390306
[TBL] [Abstract][Full Text] [Related]
15. Stepwise dose increase of febuxostat is comparable with colchicine prophylaxis for the prevention of gout flares during the initial phase of urate-lowering therapy: results from FORTUNE-1, a prospective, multicentre randomised study.
Yamanaka H; Tamaki S; Ide Y; Kim H; Inoue K; Sugimoto M; Hidaka Y; Taniguchi A; Fujimori S; Yamamoto T
Ann Rheum Dis; 2018 Feb; 77(2):270-276. PubMed ID: 29102957
[TBL] [Abstract][Full Text] [Related]
16. Gout.
Dalbeth N; Choi HK; Joosten LAB; Khanna PP; Matsuo H; Perez-Ruiz F; Stamp LK
Nat Rev Dis Primers; 2019 Sep; 5(1):69. PubMed ID: 31558729
[TBL] [Abstract][Full Text] [Related]
17. The management of gout at an academic healthcare center in Beijing: a physician survey.
Fang W; Zeng X; Li M; Chen LX; Schumacher HR; Zhang F
J Rheumatol; 2006 Oct; 33(10):2041-9. PubMed ID: 17014019
[TBL] [Abstract][Full Text] [Related]
18. Evaluating appropriate use of prophylactic colchicine for gout flare prevention.
George M; Pullman-Mooar S; Hussain F; Schumacher HR
Arthritis Care Res (Hoboken); 2014 Aug; 66(8):1258-62. PubMed ID: 24376081
[TBL] [Abstract][Full Text] [Related]
19. Treatment and prophylaxis of gout flare in the clinic: an office-based approach to gout management.
Lieberman JA
Postgrad Med; 2011 Nov; 123(6):151-65. PubMed ID: 22104464
[TBL] [Abstract][Full Text] [Related]
20. Treatment of acute gout: a systematic review.
Khanna PP; Gladue HS; Singh MK; FitzGerald JD; Bae S; Prakash S; Kaldas M; Gogia M; Berrocal V; Townsend W; Terkeltaub R; Khanna D
Semin Arthritis Rheum; 2014 Aug; 44(1):31-8. PubMed ID: 24650777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]